AKT1 and chronic graft versus host disease: Sorafenib effectively inhibited the phosphorylation of ERK but regarding AKT lower phosphorylation was only seen in the patient receiving a low dose rapamycin due to the progressive chronic GvHD (cGvHD, Fig 2B).